Abstract
The authors designed a study to determine the efficacy and toxicity of combination treatment with CCNU and NSC 82196 (5-[3,3 Bis(2 chloroethyl) 1 triazeno]imidazole 4 carboxamide) in patients with advanced (predominantly refractory) solid tumors, especially adeno carcinomas. Twenty three patients, 12 men and 11 women ranging in age from 17 to 76 years with a median age of 52, with a variety of disseminated solid tumors were treated.
Original language | English (US) |
---|---|
Pages (from-to) | 769-771 |
Number of pages | 3 |
Journal | CANCER CHEMOTHER.REP. |
Volume | 59 |
Issue number | 4 |
State | Published - 1975 |
ASJC Scopus subject areas
- General Medicine